Survival Outcomes of Rare Cutaneous Malignancies within an Insured Cohort of Patients, 1988-2018
Description
Mendeley Supplemental Figure 1: Kaplan Meier Overall Survival Curves by Race/Ethnicity for our Cohort of DFSP Diagnoses Mendeley Supplemental Figure 2: Kaplan Meier Disease-Specific Survival Curves by Race/Ethnicity for our Cohort of DFSP Diagnoses Mendeley Supplemental Figure 3: Kaplan Meier Overall Survival Curves by Race/Ethnicity for our Cohort of CAS Diagnoses Mendeley Supplemental Figure 4: Kaplan Meier Disease-Specific Survival Curves by Race/Ethnicity for our Cohort of CAS Diagnoses Mendeley Supplemental Figure 5: Kaplan Meier Overall Survival Curves by Race/Ethnicity for our Cohort of MCC Diagnoses Mendeley Supplemental Figure 6: Kaplan Meier Disease-Specific Survival Curves by Race/Ethnicity for our Cohort of MCC Diagnoses Mendeley Supplemental Figure 7: Kaplan Meier Overall Survival Curves by Race/Ethnicity for our Cohort of SC Diagnoses Mendeley Supplemental Figure 8: Kaplan Meier Disease-Specific Survival Curves by Race/Ethnicity for our Cohort of SC Diagnoses *DFSP: dermatofibrosarcoma protuberans; CAS: cutaneous angiosarcoma; MCC: Merkel cell carcinoma; SC: sebaceous carcinoma